Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Scholar Rock Holding CorporationNASDAQ: SRRK
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables turns negative
Q3 FY2026 accounts payables was -$4.8M, compared with $5.66M a year earlier. Trailing-twelve-month accounts payables was -$599K.
Context
- Accounts payables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near -$4.8M or moves back toward the trailing-twelve-month quarterly average of -$149.75K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 208K USD
- Year-over-year change
- -96.9%
- 4-year CAGR
- -32.7%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 208K | -96.9% |
| FY2024 | 2024-12-31 | 6.63M | +1353.3% |
| FY2023 | 2023-12-31 | (529K) | -110.8% |
| FY2022 | 2022-12-31 | (251K) | -124.7% |
| FY2021 | 2021-12-31 | 1.02M | — |
Accounts Payables vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 accounts payables of $599K is the 10th largest of the 11 companies compared; the peer median is $3.35M.
- Its year-over-year change of -122.2% is the lowest of 10, against a peer median of -41.5%.
- Accounts payables amounts to 105.1% of revenue for SRRK, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $39.15M | -42.1% | -10.9% | 1.8% | |
| LTM Jun 2026 | $23.17M | +98.6% | — | — | |
| LTM Sep 2026 | $11.71M | -66.8% | — | 1.2% | |
| LTM Sep 2026 | $8.53M | +1178.4% | +79.5% | — | |
| LTM Sep 2026 | $3.67M | +225.9% | -11.9% | — | |
| LTM Jun 2026 | $3.04M | -41.5% | +36.5% | 1.9% | |
| LTM Mar 2026 | $1.61M | +159.9% | -80.7% | 8.0% | |
| LTM Jun 2026 | $1.07M | -88.4% | — | 0.1% | |
| LTM Mar 2026 | $829K | -92.1% | +460.3% | 2.6% | |
| LTM Sep 2026 | $599K | -122.2% | — | 105.1% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SRRK) | $3.35M | -41.5% | +12.8% | 1.8% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 23.15M | 27.7M | 27.14M | 36.63M | 75.6M |
| Change in Working Capital | (28.44M) | (34.39M) | (10.61M) | 6.59M | (1.05M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.02M | (251K) | (529K) | 6.63M | 208K |
| Other Working Capital | (29.46M) | (34.14M) | (10.09M) | (36K) | (1.26M) |
| Other Non-Cash Items | 7.67M | 5.51M | 1.19M | 186K | 1.7M |
| Operating Cash Flow | (126.79M) | (132.69M) | (145.23M) | (200.95M) | (300.04M) |
| Capital Expenditures | (5.25M) | (1.06M) | (71K) | (98K) | (602K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (60.44M) | (300.63M) | (290.8M) | (293.16M) | (98.01M) |
| Sales of Investments | 200M | 130M | 332M | 217.2M | 317.3M |
| Other Investing Activities | 0 | 0 | 13K | 0 | 0 |
| Investing Cash Flow | 134.32M | (171.7M) | 41.14M | (76.06M) | 218.69M |
| Debt Repayment | 24.98M | (975K) | 0 | 0 | 49.14M |
| Common Stock Issued | 13.1M | 195.32M | 97.71M | 324.41M | 179.26M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 6.87M | 492K | 4.87M | 28.61M | 0 |
| Financing Cash Flow | 44.95M | 194.83M | 102.57M | 353.03M | 228.4M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | (2K) |
| Net Change in Cash | 52.48M | (109.56M) | (1.51M) | 76.02M | 147.05M |
| Free Cash Flow | (132.04M) | (133.76M) | (145.3M) | (201.05M) | (300.64M) |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.